Teva's stunning list of cuts targets 14K jobs, $3B in costs and plants around the globe | Fierce Pharma
A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New York Times
Teva to axe 14,000 jobs despite uproar in Israel | Financial Times
Teva recalls US-made drugs following contamination fears - The Boston Globe
Israeli Pharmaceutical Giant Teva To Distribute COVID-19 Vaccine In Jewish State - I24NEWS
COVID-19 Research News | Duke University School of Medicine
Men's Teva Original Universal - Walmart.com
Investors question green tint of Teva's $5bn sustainability bond | Financial Times
Israel Eyes Collaboration With Europe On Vaccine Production - As Moderna Gears Up For Major Manufacturing Expansion - Health Policy Watch
Netanyahu asks Teva Pharm to minimize job loss in Israel | Reuters
Teva is approved from FDA for Austedo XR for tardive dyskinesia
Defense Logistics Agency Awards Adenovirus Vaccine Supply Contract | Article | The United States Army
Teva, one of the biggest generic makers, joins the the brand-name club
US military vaccination programme given booster with $170m Teva deal
Q3 pharma earnings roundup: Moderna, Regeneron and Teva
Teva to cut 14,000 jobs | Business | Chemistry World
Teva Pharm expects U.S. opioid case settlements to cost $2.6 bln | Reuters
Teva and Other Generic Drugmakers Inflated Prices Up to 1,000%, State Prosecutors Say - The New York Times
Teva Reaches Tentative $4.25 Billion Settlement Over Opioids - The New York Times
/cloudfront-us-east-2.images.arcpublishing.com/reuters/AP6KIV5ZJZMMXHJ3TT4TTMV3MQ.jpg "Drugmaker Teva may pay as much as $3.6 billion in U.S. opioid settlement | Reuters")
Drugmaker Teva may pay as much as $3.6 billion in U.S. opioid settlement | Reuters
Teva says it's in talks with COVID vaccine makers to help produce shots | The Times of Israel
Big vaccine makers reject offers to help produce more jabs – POLITICO
Teva Pharmaceutical Industries Ltd. - In 2020, we've kept medicines moving. During the COVID-19 pandemic, our manufacturing, distribution and R&D sites remained open to continue supplying quality, affordable medicines to the nearly
Teva Abandons Search to Make Covid-19 Vaccine for Partners - Bloomberg
In opioid case, NY wants to probe Teva's control of Teva USA
